← Open Payments lookup

MARIA VALENA: Open Payments

NPI 1730284977 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,425 in 74 payments from 14 companies in 2025. Trend: 2023 $1,886 · 2024 $1,862 · 2025 $1,425

Food & beverage: $1,425
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$242
Vanda Pharmaceuticals Inc.14$226
Collegium Pharmaceutical, Inc.9$136
Neurocrine BioSciences, Inc.5$124
Otsuka America Pharmaceutical, Inc.6$123
ABBVIE INC.5$101
JAZZ PHARMACEUTICALS INC.3$94
Noven Therapeutics, LLC5$89
Supernus Pharmaceuticals, Inc.4$76
Axsome Therapeutics, Inc.3$68

Products named: CAPLYTA, HETLIOZ, REXULTI, Jornay PM, INGREZZA, VRAYLAR, XYWAV, Xelstrym.

Industry payments across IN — which companies pay providers there.